Neurotoxicity Syndromes
7 clinical trials · Condition
◉ Watch Neurotoxicity Syndromes
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity (NCT04150913) | Marcela V. Maus, M.D.,Ph.D. | 2020-10-01 |
| A Safety and Efficacy Study of Defibrotide in the Prevention of Chimeric Antigen Receptor-T-cell-associated Neurotoxicity (NCT03954106) | Jazz Pharmaceuticals | 2019-10-04 |
| To Study the Individual Variants of Chemotherapy-Induced Neurotoxicity (NCT02481336) | National Cheng-Kung University Hospital | 2015-03-01 |
| Scopolamine Treatment for Patients With Organophosphate Poisoning (NCT00389259) | Assaf-Harofeh Medical Center | 2007-10-01 |
| A Pilot Study of Dextromethorphan for the Prevention and Treatment of Methotrexate Neurotoxicity (NCT00176553) | University of Medicine and Dentistry of New Jersey | 2003-03-01 |
Track Neurotoxicity Syndromes automatically
Every clearance here is in the API, with alerts when new ones post.